Buspirone Hydrochloride Tablet
Product Images NDC 16729-201

Each tablet of BusPIRone Hydrochloride contains 10mg of the active ingredient. The usual dosage is specified in the package insert. The tablets must be stored between 15°C to 30°C. The container must be dispensed in a light-resistant package as defined in the USP. Keep this drug and other medicines out of the reach of children. The manufacturer is Accord Healthcare, Inc., Durham, NG 27703. The tablets are manufactured in India by Intas Pharmaceuticals Limited. The drug requires a prescription to be dispensed by the pharmacist along with the patient information leaflet. The product is available in a package size of 500 tablets.*

Each tablet of Buspirone Hydrochloride USP contains 15 mg. The package insert contains information regarding the usual dosage prescription. It should be stored between 15°C to 30°C. The medications should be kept out of children's reach and in a light-resistant container. The medicine is manufactured in India by Intas Pharmaceuticals Limited and is licensed by G139. The tablets are dispensed with a separate patient information leaflet, and the prescription requires a pharmacist. The remaining text appears to be packaging and coding information, so it is not included.*

Each tablet contains Buspirane noc 16720-200-16 Hydrochloride USP 5 mg. Usual Di: St insert for full description. Buspirone is a medication used to treat anxiety. It is supplied in tablet form with each tablet containing 5 mg of Buspirane and Hydrochloride USP. The tablets are to be stored at 25°C (77°F). They should be dispensed in a tight light-resistant container as defined by the USP. It is essential to keep this medication out of the reach of children. It is manufactured for Rx Only. The medication is manufactured by Accord Health Care, Inc., Durham, NC 27703. The patient information leaflet is provided separately.*

This is a medication called Buspirone Hydrochloride USP, with each tablet containing 7.5 mg. The usual dosage is unspecified and should be reviewed through the package insert. The medication should be kept in a tight, light-resistant USP container, with controlled foom temperature set between 15°C to 30°C. The medication was manufactured by Intas Pharmaceuticals Limited in India for Accord Healtheare, Inc., based in Durham, NC. The NDC code for the medication is 16729-201-16. A pharmacist should dispense it, and the customer should keep it away from children. The provided text also includes production details such as M.L. No, lot and expiration dates, and data matrix, while the "Keep area blank & varnish free for overcoding" suggests potential repurposing for future use.*

This text seems to be a set of instructions or information regarding dosage of tablets prescribed by a doctor. The instructions provide specific dosages for 15mg tablets and 30mg tablets, as well as the dosage equivalent for smaller amounts of tablets, such as 10mg and 20mg. It is unclear what type of medication these tablets are, but the text provides guidance on how to correctly take the prescribed dosage.*

This appears to be a medication label that mentions two different strengths of tablets: 5mg and 30mg. It doesn't provide the name or purpose of the medication, nor any other details.*